Guanfacine marketed by TWi Pharmaceuticals, Inc. under NDC Code 24979-536-01
NDC Code(s) : 24979-533-01, 24979-533-10, 24979-534-01, 24979-534-10, 24979-536-01, 24979-536-10, 24979-538-01, 24979-538-10
Packager : TWi Pharmaceuticals, Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Guanfacine
Guanfacine TABLET, EXTENDED RELEASE |
|
|
|
|
|
|
Guanfacine
Guanfacine TABLET, EXTENDED RELEASE |
|
|
|
|
|
|
Guanfacine
Guanfacine TABLET, EXTENDED RELEASE |
|
|
|
|
|
|
Guanfacine
Guanfacine TABLET, EXTENDED RELEASE |
|
|
|
|
|
|
PRINCIPAL DISPLAY PANEL
NDC 24979-533-01
Guanfacine
Extended-Release Tablets
1 mg
100-count and 1000-count
PRINCIPAL DISPLAY PANEL
NDC 24979-534-01
Guanfacine
Extended-Release Tablets
2 mg
100-count and 1000-count
PRINCIPAL DISPLAY PANEL
NDC 24979-536-01
Guanfacine
Extended-Release Tablets
3 mg
100-count and 1000-count
PRINCIPAL DISPLAY PANEL
NDC 24979-538-01
Guanfacine
Extended-Release Tablets
4 mg
100-count and 1000-count
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.